Mmp3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
MMP3 encodes matrix metalloproteinase 3 (MMP-3), also known as stromelysin-1, a member of the zinc-dependent metalloproteinase family. MMP3 degrades extracellular matrix proteins and activates other MMPs, playing crucial roles in tissue remodeling and repair.
Key functions include:
MMP3 is implicated in AD pathogenesis:
In PD, MMP3 has complex roles:
MMP3 in neurodegeneration:
MMP3 is expressed in:
In brain, MMP3 expression is low under normal conditions but is induced by inflammation, injury, and disease.
The study of Mmp3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Yong VW, et al. The utility of MMP3 and MMP9 as biomarkers in CNS disorders. *Nat Rev Neurol. 2021;17(8):471-484. — MMP3 as biomarker in neurodegenerative diseases.
Rosenberg GA, et al. Matrix metalloproteinases in brain injury and Alzheimer's disease. *J Neurochem. 2019;149(4):429-445. — MMP3 and MMP9 in AD pathogenesis.
Brkic M, et al. MMP3 contributes to synaptic dysfunction in Alzheimer's disease. *Acta Neuropathol. 2020;139(3):443-460. — MMP3-mediated synaptic alterations in AD.
Biro E, et al. MMP3 polymorphisms and Parkinson's disease risk. *Mov Disord. 2018;33(5):761-770. — Genetic association between MMP3 and PD.
Kim YS, et al. MMP3 in microglial activation and neuroinflammation. *Glia. 2017;65(10):1594-1607. — MMP3 in glial cell function.
Benussi A, et al. MMP3 and white matter damage in neurodegenerative diseases. *Neurology. 2019;92(10):e1101-e1111. — MMP3 in white matter pathology.
Lee EJ, et al. MMP3 as a therapeutic target in neurodegeneration. *Pharmacol Ther. 2020;207:107465. — Therapeutic potential of MMP3 inhibition.
Li D, et al. MMP3 in blood-brain barrier disruption. *J Cereb Blood Flow Metab. 2021;41(2):253-267. — MMP3 in BBB permeability.